Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Using alteplase to improve fluid drainage and breathlessness in patients with malignant pleural effusion

Official title: A Randomized Trial of Alteplase Versus Placebo Through an Indwelling Pleural Catheter for Management of Symptomatic Septated MPE

Run by M.D. Anderson Cancer Center · NCT06184321 · Data updated 2026-11-12

This study tests if the medication alteplase can help people with fluid buildup in the lungs feel better and breathe easier when regular drainage isn’t enough.

More Malignant Solid Neoplasm trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations2 sites (Baltimore, Maryland and 1 other locations)
StatusRecruiting
StartedAugust 17, 2023
Main results expectedFebruary 2, 2027
Study endsFebruary 2, 2027
Registry record updatedAugust 17, 2026
Trial IDNCT06184321 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with symptomatic septated malignant pleural effusion who are unable to drain fluid adequately through an indwelling pleural catheter.

Probably not a fit

Patients who cannot provide informed consent or have a blocked indwelling pleural catheter may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of alteplase, a medication that dissolves blood clots, in improving pleural fluid drainage and alleviating dyspnea in patients with symptomatic septated malignant pleural effusion who are unable to fully drain fluid through an indwelling pleural catheter. Participants are randomized into two groups: one receiving alteplase and the other receiving a placebo, with assessments of dyspnea conducted using the Borg score and visual analog scale at one week. The study aims to determine if alteplase can enhance symptom management in this patient population.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from breathlessness due to malignant pleural effusion.

How similar studies have gone: While the use of alteplase in this specific context is novel, similar approaches in other settings have shown promise in improving fluid drainage and symptom relief.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Referral to pulmonary services for inability to drain fully via IPC
* Presence of a symptomatic septated pleural effusion
* A pleural effusion of significant moderate to large volume based on:

  * Chest radiograph: effusion filling \>= 1/3 of the hemithorax, or
  * Computed tomography (CT)-scan: AP depth of the effusion \>= 1/3 of the AP dimension on the axial image superior to the hemidiaphragm, including atelectatic lung surrounded by effusion, or
  * Ultrasound: effusion spanning at least three intercostal spaces, with a \>= 3 cm in at least one intercostal space, while the patient sits upright
* Age \> 18
* Borg score \>= 3
* Absence of a blocked IPC as demonstrated by a flush with 20 cc of saline x1 without resistance
* Presence of septated effusion based on ultrasound (US) and chest CT

Exclusion Criteria:

* Inability to provide informed consent
* Study subject has any disease or condition that interferes with safe completion of the study including:

  * Uncorrectable coagulopathy based on criteria followed by cardiopulmonary center for procedures.
  * Active bleeding
  * Known allergic reaction to thrombolytics
* Pleural effusion is smaller than expected on bedside pre-procedure ultrasound
* No septations and/or no loculations on bedside pre-procedure ultrasound
* Patient is asymptomatic
* Blocked IPC as determined by saline flush

Where it's running

  • M D Anderson Cancer Center
    Houston, Texas, United States
    Recruiting
  • John Hopkins University
    Baltimore, Maryland, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.